Lv1
82 积分 2022-03-04 加入
Safety and Efficacy of QLC5508 in Previously Treated Patients with Small Cell Lung Cancer: Updated Data from a Phase 1 Study
24天前
已关闭
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
1个月前
已完结
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
1个月前
已完结
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
3个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
3个月前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer: A Randomized Clinical Trial
3个月前
已完结
Pan-cancer analysis of RNA expression signatures associated with cancer tissue architecture
5个月前
已完结
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
8个月前
已完结
Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery
10个月前
已完结
Topoisomerase I inhibitors: camptothecins and beyond
10个月前
已完结
皖公网安备34019202002308
